OverviewChartProfileKey statisticsFinancialsNewsTraderScreen

Merck & Co Inc/  US58933Y1055  /

IEX
8/12/2022  9:59:59 PM Chg. +2.09 Volume Bid- Ask- Market Capitalization Dividend Y. P/E Ratio
91.01USD +2.35% 322,133
Turnover: 29.14 mill.		 -Bid Size: - -Ask Size: - 230.58 bill.USD 2.86% 17.64
TeleTrader 7/28 Merck: EPS more than triples to $1.55 in Q2
TeleTrader 6/24 Merck advances in talks to acquire Seagen - report
TeleTrader 6/17 Merck discussing buying Seagen for $28B - report
TeleTrader 4/28 Merck's Q1 EPS up 57% to $1.70
TeleTrader 3/16 Merck halts new Russia investments
TeleTrader 2/17 South Africa authorizes Merck's COVID drug
TeleTrader 2/3 Merck's sales up by 24% to $13.52 billion in Q4
TeleTrader 1/18 Merck, Ridgeback to supply 3 million courses of molnupiravir
GlobeNewswire 1/11 Aligos Therapeutics Expands Collaboration with Merck to Develop Oligonucleotide Therapies for NASH
GlobeNewswire 1/10 NGM Bio Outlines 2022 Strategic Priorities Across Its Portfolio of Clinical-Stage Oncology, Retinal ...
TeleTrader 1/9 Italy to get 40,000 Merck COVID-19 pills next week
GlobeNewswire 1/5 F-star Therapeutics Announces Merck KGaA, Darmstadt, Germany Exercises a Fourth Licensing Option in ...
TeleTrader 12/28/2021 India approves use of Merck's COVID-19 pill
TeleTrader 12/24/2021 Merck's antiviral pill approved in Japan
TeleTrader 12/23/2021 Pfizer, Merck pills effective against Omicron - FDA official
TeleTrader 12/23/2021 FDA approves Merck's COVID-19 pill
TeleTrader 12/16/2021 Denmark grants Merck's COVID pill limited approval
TeleTrader 12/3/2021 Canada secures COVID oral antiviral treatment
TeleTrader 12/1/2021 Belgium looking to buy 10,000 Merck COVID pills
TeleTrader 11/30/2021 FDA panel backs Merck's at-home COVID pill
TeleTrader 11/26/2021 Merck revises down its COVID-19 drug efficacy
TeleTrader 11/9/2021 US to buy 1.4M courses of Merck's COVID-19 drug
TeleTrader 11/7/2021 Merck's COVID drug to be rolled out this month in UK
TeleTrader 11/4/2021 UK first in the world to approve Merck's virus drug
TeleTrader 10/28/2021 Merck's Q3 revenue rises to $13.2B after 20% jump